Nayax Q3 2026: Margin Expansion Offsets Slowing Growth

What happened

Nayax reported Q3 2026 revenue of $128 million, up 23% year-over-year, but this marks a deceleration from the 25.7% growth in Q3 2025 and remains below the 25% organic growth threshold highlighted in our prior analysis. The net loss of $1.1 million masks a positive adjusted net income of $14.1 million, driven by significant add-backs, while adjusted EBITDA of $24.2 million reflects a 19% margin, an improvement from 17.5% a year ago and above the 18% level we flagged as a positive trigger. Free cash flow of $10 million converted at only 41% of adjusted EBITDA, missing the company's own 50% conversion target and indicating continued capital intensity. Management reaffirmed original full-year 2026 guidance and raised the outlook to include the IPS Group acquisition, a move that raises concerns about inorganic support to guidance. Overall, the quarter shows margin progress but decelerating top-line growth and weak cash conversion, reinforcing our cautious view that the stock remains fully valued at ~86x EV/EBITDA.

Implication

Given the results, we see limited upside from current levels near $58; the stock still trades at ~86x EV/EBITDA, pricing in sustained >25% growth and margin expansion, but actual growth is decelerating. The improvement in adjusted EBITDA margin to 19% is a positive, but it appears driven partly by cost discipline rather than top-line leverage, and net loss remains negative. Free cash flow conversion at 41% falls short of management's 50% target, indicating the business still requires heavy investment and may not be self-funding growth as quickly as hoped. The decision to raise guidance by including IPS Group acquisition heightens our concern that inorganic contributions are propping up expectations, a pattern we flagged earlier. Therefore, we would use any strength toward the $70 trim level to reduce exposure, and would not consider adding until the stock approaches our attractive entry of $45, where the valuation would better reflect the risks of slowing growth and execution on M&A.

Thesis delta

The Q3 2026 results modestly temper our bearish stance, as adjusted EBITDA margin of 19% exceeded our 18% threshold for a positive signal and suggests operating leverage is materializing. However, revenue growth of 23% is below the 25% needed to support the current premium multiple, and free cash flow conversion of 41% remains weak. Consequently, we maintain a cautious view but reduce conviction from 4.0 to 3.5, still preferring trims over buys unless the price falls toward $45 or growth reaccelerates above 25% with sustained margin gains.